Literature DB >> 23430585

Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer.

Ya-Feng Wang1, Hai-Yang Lang, Jing Yuan, Jun Wang, Rui Wang, Xin-Hui Zhang, Jie Zhang, Tao Zhao, Yu-Rong Li, Jun-Ye Liu, Li-Hua Zeng, Guo-Zhen Guo.   

Abstract

The aim of this study was to investigate the association between keratin 17 (K17) expression and the clinicopathological features of patients with epithelial ovarian cancer (EOC). K17 expression was detected by real-time quantitative RT-PCR in EOC and adjacent noncancerous tissues. In addition, K17 expression was analyzed by immunohistochemistry in 104 clinicopathologically characterized EOC cases. The expression levels of K17 mRNA and protein in EOC tissues were both significantly higher than those in noncancerous tissues. In addition, positive expression of K17 correlated with the clinical stage (p=0.001). Furthermore, Kaplan-Meier survival analysis showed that a high expression level of K17 resulted in a significantly poor prognosis of EOC patients. Multivariate analysis revealed that EOC expression level was an independent prognostic parameter for the overall survival rate of EOC patients. Our data are the first to suggest that increased K17 expression in EOC is significantly associated with aggressive progression and poor prognosis. K17 may be an important molecular marker for predicting the carcinogenesis, progression, and prognosis of EOC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430585     DOI: 10.1007/s13277-013-0703-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  20 in total

Review 1.  Keratins in health and cancer: more than mere epithelial cell markers.

Authors:  V Karantza
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

Review 2.  Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis.

Authors:  Matteo Rota; Elena Pasquali; Lorenza Scotti; Claudio Pelucchi; Irene Tramacere; Farhad Islami; Eva Negri; Paolo Boffetta; Rino Bellocco; Giovanni Corrao; Carlo La Vecchia; Vincenzo Bagnardi
Journal:  Gynecol Oncol       Date:  2012-03-23       Impact factor: 5.482

3.  Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.

Authors:  M Wang; Y He; L Shi; C Shi
Journal:  Eur J Gynaecol Oncol       Date:  2011       Impact factor: 0.196

4.  Changes in the pattern of cytokeratin polypeptides in epidermis and hair follicles during skin development in human fetuses.

Authors:  R Moll; I Moll; W Wiest
Journal:  Differentiation       Date:  1982       Impact factor: 3.880

5.  Breast-feeding and risk of epithelial ovarian cancer.

Authors:  S J Jordan; K L Cushing-Haugen; K G Wicklund; J A Doherty; M A Rossing
Journal:  Cancer Causes Control       Date:  2012-04-24       Impact factor: 2.506

6.  Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers.

Authors:  Aye Aye Thike; Jabed Iqbal; Poh Yian Cheok; Angela Phek Yoon Chong; Gary Man-Kit Tse; Benita Tan; Patrick Tan; Nan Soon Wong; Puay Hoon Tan
Journal:  Am J Surg Pathol       Date:  2010-07       Impact factor: 6.394

7.  Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.

Authors:  N S Goldstein; D Bassi
Journal:  Am J Clin Pathol       Date:  2001-05       Impact factor: 2.493

8.  Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma.

Authors:  Munenori Ide; Toshihide Kato; Kyoichi Ogata; Erito Mochiki; Hiroyuki Kuwano; Tetsunari Oyama
Journal:  Ann Surg Oncol       Date:  2012-06-14       Impact factor: 5.344

9.  Overexpression of cytokeratin 17 protein in oral squamous cell carcinoma in vitro and in vivo.

Authors:  K-J Wei; L Zhang; X Yang; L-P Zhong; X-J Zhou; H-Y Pan; J Li; W-T Chen; Z-Y Zhang
Journal:  Oral Dis       Date:  2008-11-03       Impact factor: 3.511

10.  Patterns of expression of keratin 17 in human epithelia: dependency on cell position.

Authors:  S M Troyanovsky; V I Guelstein; T A Tchipysheva; V A Krutovskikh; G A Bannikov
Journal:  J Cell Sci       Date:  1989-07       Impact factor: 5.285

View more
  22 in total

1.  Gene Expression Differences in Pediatric Lymphatic Malformations: Size Really Matters.

Authors:  Horacio Gomez-Acevedo; James R Dornhoffer; Annjanette Stone; Yuemeng Dai; Gresham T Richter
Journal:  Lymphat Res Biol       Date:  2018-08       Impact factor: 2.589

2.  Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells.

Authors:  Mihaela Chivu-Economescu; Denisa L Dragu; Laura G Necula; Lilia Matei; Ana Maria Enciu; Coralia Bleotu; Carmen C Diaconu
Journal:  Gastric Cancer       Date:  2017-03-15       Impact factor: 7.370

3.  A role for keratin 17 during DNA damage response and tumor initiation.

Authors:  Raji R Nair; Joshua Hsu; Justin T Jacob; Christopher M Pineda; Ryan P Hobbs; Pierre A Coulombe
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

4.  Overexpression of cytokeratin 17 is associated with the development of papillary thyroid carcinoma and the presence of lymph node metastasis.

Authors:  Hyun-Soo Kim; Jeong-Ju Lee; Sung-Im Do; Kyungeun Kim; In-Gu Do; Dong-Hoon Kim; Seoung Wan Chae; Jin Hee Sohn
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Rab14 is overexpressed in ovarian cancers and promotes ovarian cancer proliferation through Wnt pathway.

Authors:  Rui Hou; Luo Jiang; Zhuo Yang; Shizhuo Wang; Qifang Liu
Journal:  Tumour Biol       Date:  2016-10-07

6.  Stress Keratin 17 Expression in Head and Neck Cancer Contributes to Immune Evasion and Resistance to Immune-Checkpoint Blockade.

Authors:  Wei Wang; Taja Lozar; Athena E Golfinos; Denis Lee; Ellery Gronski; Ella Ward-Shaw; Mitchell Hayes; Justine Y Bruce; Randall J Kimple; Rong Hu; Paul M Harari; Jin Xu; Aysenur Keske; Paul M Sondel; Megan B Fitzpatrick; Huy Q Dinh; Paul F Lambert
Journal:  Clin Cancer Res       Date:  2022-07-01       Impact factor: 13.801

7.  Loss of Keratin 17 induces tissue-specific cytokine polarization and cellular differentiation in HPV16-driven cervical tumorigenesis in vivo.

Authors:  R P Hobbs; A S Batazzi; M C Han; P A Coulombe
Journal:  Oncogene       Date:  2016-04-11       Impact factor: 9.867

8.  Expression and biological role of cytoglobin in human ovarian cancer.

Authors:  Haiying Chen; Xia Zhao; Tao Meng
Journal:  Tumour Biol       Date:  2014-04-17

9.  Overexpression of CARMA3 is associated with advanced tumor stage, cell cycle progression, and cisplatin resistance in human epithelial ovarian cancer.

Authors:  Chengyao Xie; Yong Han; Lin Fu; Qingchang Li; Xueshan Qiu; Enhua Wang
Journal:  Tumour Biol       Date:  2014-05-16

10.  Keratin 17 Is a Novel Cytologic Biomarker for Urothelial Carcinoma Diagnosis.

Authors:  Sruthi Babu; Nam W Kim; Maoxin Wu; Ina Chan; Luisa F Escobar-Hoyos; Kenneth R Shroyer
Journal:  Am J Clin Pathol       Date:  2021-10-13       Impact factor: 5.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.